SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-077055
Filing Date
2023-06-30
Accepted
2023-06-30 16:01:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2320301d1_sc13ga.htm SC 13G/A 36932
  Complete submission text file 0001104659-23-077055.txt   38291
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43603 | Film No.: 231061579
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 185 SOUTH DREXEL AVEUE BEXLEY OH 43209
Business Address
Bain Irwin Allen (Filed by) CIK: 0001949247 (see all company filings)

Type: SC 13G/A